Trial design {8}
The BOHEMIA clinical trial has been designed in accordance with VCAG recommendations for conducting Phase III trials of traditional vector control tools in two different epidemiological settings [The clinical trial will be open-label, superiority, cluster randomized, controlled, parallel arm trial and will last one year. Given the nature of endectocides, which provide indirect protection through a community effect, the intervention must be randomized in clusters.